<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18027/2224-5057-2012-1-7-14</article-id><article-id custom-type="elpub" pub-id-type="custom">tumors-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ КОНФЕРЕНЦИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURE</subject></subj-group></article-categories><title-group><article-title>РАК МОЛОЧНОЙ ЖЕЛЕЗЫ И БЕРЕМЕННОСТЬ</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пароконная</surname><given-names>А. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каширское шоссе 24, Москва 115478</p></bio><email xlink:type="simple">ANAPAR1@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Российский онкологический научный центр им. Н.Н. Блохина РАМН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>19</day><month>05</month><year>2015</year></pub-date><volume>2</volume><issue>1</issue><fpage>7</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пароконная А.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Пароконная А.А.</copyright-holder><copyright-holder xml:lang="en">Пароконная А.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/15">https://www.malignanttumors.org/jour/article/view/15</self-uri><abstract><p>За последние 10 лет заболеваемость раком молочной железы (РМЖ) выросла на 32,5%, при этом с каждым годом растет число женщин, заболевших в более молодом возрасте. Одновременно увеличивается и число женщин, которые планируют беременность после 30-35 лет. Следовательно, можно ожидать, что сближение этих возрастных групп может привести в ближайшие годы к росту заболеваемости РМЖ у беременных и лактирующих женщин. Трудности диагностики объективного (увеличение объема и изменение консистенции молочных желез, осложнение лактации) и субъективного (психологическая «неготовность» к диагнозу злокачественной опухоли и у больной, и у врача) характера приводят к позднему выявлению опухоли у беременных женщин; лечение начинается при более распространенных стадиях болезни, чем в общей популяции пациентов. В лекции рассматриваются вопросы диагностики и лечения этой категории больных.</p></abstract><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>беременность</kwd><kwd>диагностика</kwd><kwd>лечение</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Decker S., Amant F. Breast cancer in pregnancy: a literature review // F,V&amp; V in ObGyn . – 2009. – Vol. 1 (2). – P.130-141.</mixed-citation><mixed-citation xml:lang="en">Decker S., Amant F. Breast cancer in pregnancy: a literature review // F,V&amp; V in ObGyn . – 2009. – Vol. 1 (2). – P.130-141.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Loibl S, Von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D. Breast carcinoma during pregnancy. International recommendations from an expert meeting // Cancer. – 2006. – Vol.106. – P.237-46.</mixed-citation><mixed-citation xml:lang="en">Loibl S, Von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D. Breast carcinoma during pregnancy. International recommendations from an expert meeting // Cancer. – 2006. – Vol.106. – P.237-46.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Amant F, Van Calsteren K, Vergote I, Ottevanger N. Gynecologic oncology in pregnancy // Critical Reviews in Oncology Hematology. – 2008. – Vol.67. –P.187-195.</mixed-citation><mixed-citation xml:lang="en">Amant F, Van Calsteren K, Vergote I, Ottevanger N. Gynecologic oncology in pregnancy // Critical Reviews in Oncology Hematology. – 2008. – Vol.67. –P.187-195.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Monego M., Royo M., Espinos J. Pregnancy associated breast cancer // Eur J Surg Oncol. – 2008. – P. 1-4.</mixed-citation><mixed-citation xml:lang="en">Garcia-Monego M., Royo M., Espinos J. Pregnancy associated breast cancer // Eur J Surg Oncol. – 2008. – P. 1-4.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gentilini O, Masullo M, Rotmensz N, Peccatori F, Mazzarol G, Smeets A Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options // Eur J Surg Oncol. –2005. –Vol. 31(3) . – P. 232–6.</mixed-citation><mixed-citation xml:lang="en">Gentilini O, Masullo M, Rotmensz N, Peccatori F, Mazzarol G, Smeets A Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options // Eur J Surg Oncol. –2005. –Vol. 31(3) . – P. 232–6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gwyn K, Theriault R. Breast cancer during pregnancy // Oncology (Huntingt) . – 2001. – Vol.15. –P.39-46.</mixed-citation><mixed-citation xml:lang="en">Gwyn K, Theriault R. Breast cancer during pregnancy // Oncology (Huntingt) . – 2001. – Vol.15. –P.39-46.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Holleb A.I., Farrow J.H. The relation of carcinoma of the breast and pregnancy in 283 patients // Surg. Gynecol. Obstet. – 1962. – Vol. 115. – P. 65.</mixed-citation><mixed-citation xml:lang="en">Holleb A.I., Farrow J.H. The relation of carcinoma of the breast and pregnancy in 283 patients // Surg. Gynecol. Obstet. – 1962. – Vol. 115. – P. 65.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Navrozoglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos EN, Zoras O, Paraskevaidis E. Breast cancer during pregnancy: a mini-review // Eur J Surg Oncol. – 2008. –Vol.34. –P.837-843.</mixed-citation><mixed-citation xml:lang="en">Navrozoglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos EN, Zoras O, Paraskevaidis E. Breast cancer during pregnancy: a mini-review // Eur J Surg Oncol. – 2008. –Vol.34. –P.837-843.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Пароконная А.А. Рак молочной железы и беременность (особенности клиники, диагностики и лечения, прогноз). Дис. … д-ра мед. наук. – Москва, 2009.</mixed-citation><mixed-citation xml:lang="en">Пароконная А.А. Рак молочной железы и беременность (особенности клиники, диагностики и лечения, прогноз). Дис. … д-ра мед. наук. – Москва, 2009.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rosemond G. Carcinoma of the breast during pregnancy // Clin. Obstet. Cynecol., 1963. – Vol. 6. – P. 994-1001.</mixed-citation><mixed-citation xml:lang="en">Rosemond G. Carcinoma of the breast during pregnancy // Clin. Obstet. Cynecol., 1963. – Vol. 6. – P. 994-1001.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rissanen P. Carcinoma of the breast during pregnancy and lactation // Brit. J.Cancer, 1968. – Vol. 22. – P. 663-668.</mixed-citation><mixed-citation xml:lang="en">Rissanen P. Carcinoma of the breast during pregnancy and lactation // Brit. J.Cancer, 1968. – Vol. 22. – P. 663-668.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, et al. Effect of pregnancy on prognosis for young women with breast cancer // Lancet – 1994. – Vol.343(8913) . – P.1587–9.</mixed-citation><mixed-citation xml:lang="en">Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, et al. Effect of pregnancy on prognosis for young women with breast cancer // Lancet – 1994. – Vol.343(8913) . – P.1587–9.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nettleton J., Long J., Kuban D., Wu R., Shaeffer J., El-Mahdi A. Breast cancer during pregnancy: quantifying the risk of treatment delay // Obstet Gynecol., 1996. – Vol. 87. – P. 414-418. 14. Pavlidis N. Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer ? // Eur J Cancer. . – 2011. – Vol. 47 Suppl 3:S348-52.</mixed-citation><mixed-citation xml:lang="en">Nettleton J., Long J., Kuban D., Wu R., Shaeffer J., El-Mahdi A. Breast cancer during pregnancy: quantifying the risk of treatment delay // Obstet Gynecol., 1996. – Vol. 87. – P. 414-418. 14. Pavlidis N. Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer ? // Eur J Cancer. . – 2011. – Vol. 47 Suppl 3:S348-52.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn BY, Kim HH, Moon WK, Pisano ED, Kim HS, Cha ES, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings // J Ultrasound Med. – 2003. – Vol.22. – P.491–7.</mixed-citation><mixed-citation xml:lang="en">Ahn BY, Kim HH, Moon WK, Pisano ED, Kim HS, Cha ES, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings // J Ultrasound Med. – 2003. – Vol.22. – P.491–7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Liberman L, Gliess CS, Dershaw DD, Deutch BM, Petrek JA. Imaging of pregnancy-associated breast cancer // Radiology. – 1994. –Vol.191. –P.245–8.</mixed-citation><mixed-citation xml:lang="en">Liberman L, Gliess CS, Dershaw DD, Deutch BM, Petrek JA. Imaging of pregnancy-associated breast cancer // Radiology. – 1994. –Vol.191. –P.245–8.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P, et al. Radiological evaluation of breast disorders related to pregnancy and lactation // Radiographics. – 2007. – Vol.27. – P.101–24.</mixed-citation><mixed-citation xml:lang="en">Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P, et al. Radiological evaluation of breast disorders related to pregnancy and lactation // Radiographics. – 2007. – Vol.27. – P.101–24.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, et al. Multidisciplinary management of breast cancer concurrent with pregnancy // J Am Coll Surg. – 2002. – Vol.194. –P.54–64.</mixed-citation><mixed-citation xml:lang="en">Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, et al. Multidisciplinary management of breast cancer concurrent with pregnancy // J Am Coll Surg. – 2002. – Vol.194. –P.54–64.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Woo J.C, Taechin Y., Hurd TC. Breast cancer in pregnancy. A literature review // Arch Surg. – 2003. – Vol. 138. – P. 91-98.</mixed-citation><mixed-citation xml:lang="en">Woo J.C, Taechin Y., Hurd TC. Breast cancer in pregnancy. A literature review // Arch Surg. – 2003. – Vol. 138. – P. 91-98.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Oto A, Ernst R, Jesse MK, Chaljub G, Saade G. Magnetic resonance imaging of the chest, abdomen and pelvis in the evaluation of pregnant patients with neoplasms // Am J Perinatol. – 2007. – Vol. 24. –P.243-250.</mixed-citation><mixed-citation xml:lang="en">Oto A, Ernst R, Jesse MK, Chaljub G, Saade G. Magnetic resonance imaging of the chest, abdomen and pelvis in the evaluation of pregnant patients with neoplasms // Am J Perinatol. – 2007. – Vol. 24. –P.243-250.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ayyappan A., Kulkarni S, Cristal P. Pregnancy-associated breast cancer: spectrum of imaging appearances // The British Institute of Radiology. – Vol. 2010. – P. 1-6.</mixed-citation><mixed-citation xml:lang="en">Ayyappan A., Kulkarni S, Cristal P. Pregnancy-associated breast cancer: spectrum of imaging appearances // The British Institute of Radiology. – Vol. 2010. – P. 1-6.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N; ESMO Guidelines Working Group. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann Oncol. – 2010 May. –21 Suppl 5:v 266-73.</mixed-citation><mixed-citation xml:lang="en">Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N; ESMO Guidelines Working Group. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann Oncol. – 2010 May. –21 Suppl 5:v 266-73.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zanotti-Fregonara P, Champion Ch, Trebossen R, Maroy R, Devaux JY, Hindie E. Estimation of the .+ dose to the embryo resulting from 18F-FDG administration during early pregnancy // J Nucl Med. – 2008. – Vol.49. – P.679-682.</mixed-citation><mixed-citation xml:lang="en">Zanotti-Fregonara P, Champion Ch, Trebossen R, Maroy R, Devaux JY, Hindie E. Estimation of the .+ dose to the embryo resulting from 18F-FDG administration during early pregnancy // J Nucl Med. – 2008. – Vol.49. – P.679-682.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM. Pregnancy and breast cancer: a population-based study // Virchows Arch. – 2003. – Vol. 443(1) . –P.44–50.</mixed-citation><mixed-citation xml:lang="en">Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM. Pregnancy and breast cancer: a population-based study // Virchows Arch. – 2003. – Vol. 443(1) . –P.44–50.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ishida T., Yokoe T., Kasumi F. et al. Clinicopathological characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan // Jpn. J. Cancer Res., 1992. – Vol. 83. – P. 1143-1149.</mixed-citation><mixed-citation xml:lang="en">Ishida T., Yokoe T., Kasumi F. et al. Clinicopathological characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan // Jpn. J. Cancer Res., 1992. – Vol. 83. – P. 1143-1149.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Johannsson O., Borg A., Olsson H. Pregnancyassociated breast cancer in BRCA1 and BRCA2 germline mutation carries // Lancet. – 1998. – P. 1359-1360.</mixed-citation><mixed-citation xml:lang="en">Johannsson O., Borg A., Olsson H. Pregnancyassociated breast cancer in BRCA1 and BRCA2 germline mutation carries // Lancet. – 1998. – P. 1359-1360.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Shen T., Vortmeyer A.O., Zhuang Z., Tavassoli F.A. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma // J. Natl. Cancer Inst. – 1999. – Vol. 91. – P. 1686-1687.</mixed-citation><mixed-citation xml:lang="en">Shen T., Vortmeyer A.O., Zhuang Z., Tavassoli F.A. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma // J. Natl. Cancer Inst. – 1999. – Vol. 91. – P. 1686-1687.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Doll DC, Ringenberg QS, Yarbo JW. Antineoplastic agents and pregnancy // Semin Onc. – 1989. – Vol.16. – P.337-45.</mixed-citation><mixed-citation xml:lang="en">Doll DC, Ringenberg QS, Yarbo JW. Antineoplastic agents and pregnancy // Semin Onc. – 1989. – Vol.16. – P.337-45.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy // Arch Intern Med. – 1992. –Vol.152. –P.573-6.</mixed-citation><mixed-citation xml:lang="en">Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy // Arch Intern Med. – 1992. –Vol.152. –P.573-6.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy // Lancet Oncol. – 2004. – Vol.5. – P.283-91.</mixed-citation><mixed-citation xml:lang="en">Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy // Lancet Oncol. – 2004. – Vol.5. – P.283-91.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Chemotherapy during pregnancy: what is really safe? // Lancet Oncol. – 2004. – Vol.5. –P.398.</mixed-citation><mixed-citation xml:lang="en">Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Chemotherapy during pregnancy: what is really safe? // Lancet Oncol. – 2004. – Vol.5. –P.398.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lenhard MS, Bauerfeind I, Untch M. Breast cancer and pregnancy: challenges of chemotherapy // Critical Reviews in Oncology/Hematology. – 2008. – Vol.67. – P.196-203.</mixed-citation><mixed-citation xml:lang="en">Lenhard MS, Bauerfeind I, Untch M. Breast cancer and pregnancy: challenges of chemotherapy // Critical Reviews in Oncology/Hematology. – 2008. – Vol.67. – P.196-203.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G.Favorable pregnancy outcome following Trastuzumab (Herceptin®) use during pregnancy – Case report and updated literature review // Reprod Toxicol. – 2007. – Vol.23. – P.611-613.</mixed-citation><mixed-citation xml:lang="en">Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G.Favorable pregnancy outcome following Trastuzumab (Herceptin®) use during pregnancy – Case report and updated literature review // Reprod Toxicol. – 2007. – Vol.23. – P.611-613.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Berger JC, Clericuzio CL. Clinical report: Pierre Robin sequence associated with first trimester fetal tamoxifen exposure // Am J Med Genet Part A. – 2008. – Vol.146A. –P.2141-2144.</mixed-citation><mixed-citation xml:lang="en">Berger JC, Clericuzio CL. Clinical report: Pierre Robin sequence associated with first trimester fetal tamoxifen exposure // Am J Med Genet Part A. – 2008. – Vol.146A. –P.2141-2144.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Stensheim H, Moller B, Van Dijk T, Fossa S. Causespecific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study // J Clin Oncol. – 2009. – Vol.27. –P.45-51.</mixed-citation><mixed-citation xml:lang="en">Stensheim H, Moller B, Van Dijk T, Fossa S. Causespecific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study // J Clin Oncol. – 2009. – Vol.27. –P.45-51.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
